IDO activity has been assessed in serum [13] and pleural fluid [14], and, with a significant increase in the serum Kyn/Trp ratio, it can be used as a biomarker for TB patients infected with human immunodeficiency virus [15] and for patients with multidrug-resistant TB [16]. The gene discussed is IDO1; the disease is tuberculosis.